$50m would suffice if B-OM was going in to a P2 not a P3.
$150m+ Bank on it...
33% of P2 drugs make to P3. A lot of risk. BP did not have to take that risk so now that pay thru the nose for p3 B-om.
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
-
-
-
-
-
-
-